Celltex Recognizes October as Raynaud’s Disease Awareness Month
This October marks the first “Raynaud’s Disease Awareness Month” in the United States. Approximately five to 10 percent of all Americans suffer from Raynaud’s disease. The Raynaud’s Association declared October the official awareness month to share information regarding the disease and to highlight the condition on a national scale. While this awareness month is new to the United States, Houston based-biotechnology company, Celltex Therapeutics, has been actively working to provide relief to those affected by Raynaud’s using autologous (one’s own), adult mesenchymal stem cells (MSCs).
Raynaud’s disease, first recognized as a condition in 1862 by French physician Maurice Raynaud, causes the interruption of blood flow to areas of the body such as fingers and toes, making these areas feel numb and cold in response to cold temperatures or stress. Often, these areas of the body turn white, blue or red during an episode, and can cause tingling, swelling and painful throbbing. A Raynaud’s episode may last a few minutes or, in more severe cases, hours, and can sometimes cause ulcerations and infections leading to gangrene. While both men and women suffer from Raynaud’s, women are nine times more likely to be affected. It has been estimated that as many as 20 percent of all women in their childbearing years have Raynaud’s. Even though Raynaud’s disease is not debilitating, it can affect a person’s quality of life.
Celltex Therapeutics is using its proprietary stem cell culturing and banking technology to effectively improve the quality of life for those living with Raynaud’s through therapy, using one’s own MSCs. The process for obtaining a client’s MSCs begins with a small thumb-sized extraction of abdominal fat. The MSCs are isolated from the fat, cultured and stored cryogenically for future use. An individual can use his or her banked adult stem cells for regenerative therapy through infusions or injections performed by licensed physicians at Hospital Galenia in Cancun.
Kathi Jones is sharing her adult stem cell story after undergoing Celltex adult stem cell therapy in 2011. After suffering with Raynaud’s for years and growing tired of painful, numb fingers every time she stepped into the cold, Jones decided to reach out to Celltex. Just weeks after her first transfusion, Jones noticed a dramatic difference in her quality of life. Jones no longer experiences painfully numb and blanched fingers after trips to the grocery store’s freezer section, nor does it take exhausting periods of time to regain circulation in her fingers after she encounters cold weather.
“After receiving my own stem cells from Celltex, I finally felt as if I had my life back,” Jones says. “Simple tasks such as a run to the grocery store were becoming crippling to my everyday life, but after my therapies, I am able to live life without the pain of Raynaud’s.”